SUDA Pharmaceuticals Ltd (ASX:SUD) (FRA:E4N) enjoyed a productive first half of FY21, securing TGA approval for its ZolpiMist..
Therapeutic Goods Administration
News and Video Search Results
You might like
Therapeutic Goods Administration media coverage
Paradigm Biopharmaceuticals' additional data on Zilosul® patients under the TGA SAS shows very consistent reduction in pain of nearly 50%
Paradigm Biopharmaceuticals Ltd’s (ASX:PAR) additional data on patients who received Zilosul® under the Therapeutic Goods..
In the past 10 months, the Therapeutic Goods Administration has received 44 complaints about the thermometers which often greet..